D. Rey

1.4k total citations
30 papers, 550 citations indexed

About

D. Rey is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, D. Rey has authored 30 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 14 papers in Infectious Diseases and 14 papers in Hepatology. Recurrent topics in D. Rey's work include Hepatitis C virus research (13 papers), Hepatitis B Virus Studies (11 papers) and HIV/AIDS Research and Interventions (10 papers). D. Rey is often cited by papers focused on Hepatitis C virus research (13 papers), Hepatitis B Virus Studies (11 papers) and HIV/AIDS Research and Interventions (10 papers). D. Rey collaborates with scholars based in France, Martinique and United States. D. Rey's co-authors include Jean-Marie Lang, Carine Schmitt, Françoise Stoll‐Keller, B. Cribier, P. Meyer, Lise Cuzin, Clotilde Allavena, Stanislas Pol, C. Michelet and A. Kirn and has published in prestigious journals such as PLoS ONE, Hepatology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

D. Rey

30 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Rey France 14 295 255 212 141 117 30 550
Paola Cicconi Italy 17 351 1.2× 130 0.5× 489 2.3× 369 2.6× 301 2.6× 45 881
Mas Chaponda United Kingdom 12 323 1.1× 85 0.3× 156 0.7× 50 0.4× 35 0.3× 21 554
Marek Beniowski Poland 13 288 1.0× 108 0.4× 690 3.3× 272 1.9× 429 3.7× 32 890
Pavel Khaykin Germany 10 249 0.8× 73 0.3× 226 1.1× 195 1.4× 83 0.7× 30 530
Gerard H.C. Mientjes Netherlands 12 407 1.4× 128 0.5× 251 1.2× 132 0.9× 38 0.3× 14 560
Giuseppe Paraninfo Italy 13 249 0.8× 184 0.7× 249 1.2× 171 1.2× 101 0.9× 25 499
Miguel A García-Viejo Spain 9 317 1.1× 167 0.7× 761 3.6× 470 3.3× 533 4.6× 11 1.0k
Tanakorn Apornpong Thailand 10 152 0.5× 40 0.2× 134 0.6× 130 0.9× 129 1.1× 40 344
Heribert Knechten Germany 15 170 0.6× 58 0.2× 512 2.4× 435 3.1× 117 1.0× 44 691
Ángeles Castro‐Iglesias Spain 12 227 0.8× 222 0.9× 247 1.2× 119 0.8× 55 0.5× 35 458

Countries citing papers authored by D. Rey

Since Specialization
Citations

This map shows the geographic impact of D. Rey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Rey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Rey more than expected).

Fields of papers citing papers by D. Rey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Rey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Rey. The network helps show where D. Rey may publish in the future.

Co-authorship network of co-authors of D. Rey

This figure shows the co-authorship network connecting the top 25 collaborators of D. Rey. A scholar is included among the top collaborators of D. Rey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Rey. D. Rey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gantner, Pierre, Clotilde Allavena, Claudine Duvivier, et al.. (2020). Post‐exposure prophylaxis completion and condom use in the context of potential sexual exposure to HIV*. HIV Medicine. 21(7). 463–469. 4 indexed citations
2.
Cuzin, Lise, Cyrille Delpierre, Clotilde Allavena, et al.. (2019). Too fast to stay on track? Shorter time to first anti-retroviral regimen is not associated with better retention in care in the French Dat’AIDS cohort. PLoS ONE. 14(9). e0222067–e0222067. 13 indexed citations
3.
Cuzin, Lise, P. Dellamonica, Yazdan Yazdanpanah, et al.. (2016). Characteristics and consequences of medical care interruptions in HIV-infected patients in France. Epidemiology and Infection. 144(11). 2363–2370. 7 indexed citations
4.
Flandre, Philippe, P. Puglièse, Clotilde Allavena, et al.. (2015). Comparative risk of failure of ABC/3TC or TDF/FTC based first‐line regimens in patients with a high viral load. HIV Medicine. 17(5). 380–384. 4 indexed citations
5.
Allavena, Clotilde, Cyrille Delpierre, Lise Cuzin, et al.. (2012). High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs. Journal of Antimicrobial Chemotherapy. 67(9). 2222–2230. 62 indexed citations
6.
Piroth, Lionel, Isabelle Fournel, Sophie Mahy, et al.. (2011). A decision tree to help determine the best timing and antiretroviral strategy in HIV-infected patients. Epidemiology and Infection. 139(12). 1835–1844. 4 indexed citations
7.
Rey, D., M Partisani, Jean-Marie Lang, et al.. (2010). Insuffisance de couverture vaccinale d’une cohorte française de patients séropositifs VIH. Médecine et Maladies Infectieuses. 40(12). 683–690. 19 indexed citations
8.
Rey, D., Bruno Hoën, P. Chavanet, et al.. (2008). High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients. Journal of Antimicrobial Chemotherapy. 63(2). 380–388. 39 indexed citations
9.
Rosenthal, Éric, Gilles Pialoux, N. Bernard, et al.. (2006). Liver‐related mortality in human‐immunodeficiency‐virus‐infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study)*. Journal of Viral Hepatitis. 14(3). 183–188. 106 indexed citations
10.
Sène, D., Stanislas Pol, Lionel Piroth, et al.. (2006). Hepatitis B virus-human immunodeficiency virus co-infection in France: a cross-sectional multicentre study. Epidemiology and Infection. 135(3). 409–416. 3 indexed citations
11.
Rey, D., M Partisani, Geneviève Chêne, et al.. (2005). Séroprévalence de l'hépatite A chez des patients infectés par le VIH. Médecine et Maladies Infectieuses. 35(7-8). 402–406. 3 indexed citations
12.
Benhamou, Y., Christophe Piketty, Christine Katlama, et al.. (2003). 1155 Efficacy of tenofovir disoproxil fumarate (TDF) for hepatitis B virus (HBV) in human immunodeficiency virus (HIV) infected patients. Hepatology. 38. 712–713. 5 indexed citations
13.
Rey, D., et al.. (2001). Quantitation of hepatitis C virus RNA in saliva and serum of patients coinfected with HCV and human immunodeficiency virus. Journal of Medical Virology. 63(2). 117–119. 3 indexed citations
14.
15.
Rey, D., et al.. (2000). High Prevalence of GB Virus C/Hepatitis G Virus RNA and Antibodies in Patients Infected with Human Immunodeficiency Virus Type 1. European Journal of Clinical Microbiology & Infectious Diseases. 19(9). 721–724. 34 indexed citations
16.
Rey, D., et al.. (1999). High prevalence of GB virus C/hepatitis G virus RNA in patients infected with human immunodeficiency virus. Journal of Medical Virology. 57(1). 75–79. 24 indexed citations
17.
Rey, D., C. Saussine, Yves Hansmann, et al.. (1999). Isolated Renal Aspergillus Abscess in an AIDS Patient with a Normal CD4+ Cell Count on Highly Active Antiretroviral Therapy. European Journal of Clinical Microbiology & Infectious Diseases. 18(2). 137–141. 11 indexed citations
18.
Chakfé, Nabil, D. Rey, Jean Sibilia, et al.. (1999). Thoracoscopic Sympathectomy for Ischaemic Lesions Related to Bleomycin Therapy for Acquired Immune Deficiency Syndrome-related Kaposi's Sarcoma. European Journal of Vascular and Endovascular Surgery. 17(2). 175–177. 1 indexed citations
19.
Cribier, B., Carine Schmitt, D. Rey, et al.. (1997). HIV increases hepatitis C viraemia irrespective of the hepatitis C virus genotype. Research in Virology. 148(4). 267–271. 44 indexed citations
20.
Cribier, B., Carine Schmitt, D. Rey, et al.. (1996). Role of endogenous interferon in hepatitis C virus (HGV) infection and in coinfection by HIV and HCV. Research in Virology. 147(5). 263–266. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paola Cicconi Breakdown of academic impact, for papers by Mas Chaponda Breakdown of academic impact, for papers by Marek Beniowski Breakdown of academic impact, for papers by Pavel Khaykin Breakdown of academic impact, for papers by Gerard H.C. Mientjes Breakdown of academic impact, for papers by Giuseppe Paraninfo Breakdown of academic impact, for papers by Miguel A García-Viejo Breakdown of academic impact, for papers by Tanakorn Apornpong Breakdown of academic impact, for papers by Heribert Knechten Breakdown of academic impact, for papers by Ángeles Castro‐Iglesias
Rankless by CCL
2026